BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 18713119)

  • 1. The CARI guidelines. Pharmacological approaches to preventing vascular access failure.
    Polkinghorne K;
    Nephrology (Carlton); 2008 Jul; 13 Suppl 2():S12-6. PubMed ID: 18713119
    [No Abstract]   [Full Text] [Related]  

  • 2. The CARI guidelines. Vascular access surveillance.
    Polkinghorne K;
    Nephrology (Carlton); 2008 Jul; 13 Suppl 2():S1-11. PubMed ID: 18713118
    [No Abstract]   [Full Text] [Related]  

  • 3. The optimal initial choice for permanent arteriovenous hemodialysis access.
    Sgroi MD; Patel MS; Wilson SE; Jennings WC; Blebea J; Huber TS
    J Vasc Surg; 2013 Aug; 58(2):539-48. PubMed ID: 23890446
    [No Abstract]   [Full Text] [Related]  

  • 4. Maintaining vascular access: the management of hemodialysis arteriovenous grafts.
    Schild AF
    J Vasc Access; 2010; 11(2):92-9. PubMed ID: 20155717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality Improvement Guidelines for Percutaneous Image-Guided Management of the Thrombosed or Dysfunctional Dialysis Circuit.
    Dariushnia SR; Walker TG; Silberzweig JE; Annamalai G; Krishnamurthy V; Mitchell JW; Swan TL; Wojak JC; Nikolic B; Midia M;
    J Vasc Interv Radiol; 2016 Oct; 27(10):1518-30. PubMed ID: 27622727
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of access surveillance and preemptive intervention.
    Work J
    Semin Vasc Surg; 2011 Jun; 24(2):137-42. PubMed ID: 21889103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endovascular dialysis interventions in the era of DOQI.
    Greenberg JI; Suliman A; Angle N
    Ann Vasc Surg; 2008 Sep; 22(5):657-62. PubMed ID: 18619775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some old drugs improve late primary patency rate of native arteriovenous fistulas in hemodialysis patients.
    Righetti M; Ferrario G; Serbelloni P; Milani S; Tommasi A
    Ann Vasc Surg; 2009; 23(4):491-7. PubMed ID: 18973987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stent graft or balloon angioplasty alone for dialysis-access grafts.
    Tokmak F; Krämer BK; Krüger B
    N Engl J Med; 2010 May; 362(20):1939; author reply 1940. PubMed ID: 20496466
    [No Abstract]   [Full Text] [Related]  

  • 10. Preventing arteriovenous shunt failure in hemodialysis patients: a population-based cohort study.
    Fan PY; Lee CC; Liu SH; Li IJ; Weng CH; Tu KH; Hsieh MY; Kuo CF; Chang TY; Tian YC; Yang CW; Wu HH
    J Thromb Haemost; 2019 Jan; 17(1):77-87. PubMed ID: 30472783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombolysis for the treatment of thrombosed hemodialysis access grafts.
    Cynamon J; Pierpont CE
    Rev Cardiovasc Med; 2002; 3 Suppl 2():S84-91. PubMed ID: 12556747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dialysis access.
    Stone PA; Mousa AY; Campbell JE; AbuRahma AF
    Ann Vasc Surg; 2012 Jul; 26(5):747-53. PubMed ID: 22296951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seminars in Vascular Surgery. Contemporary issues in hemodialysis access. Introduction.
    Huber TS; Cull DL
    Semin Vasc Surg; 2011 Jun; 24(2):61-2. PubMed ID: 21889092
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug eluting grafts for hemodialysis access.
    Glickman M
    J Vasc Access; 2017 Mar; 18(Suppl. 1):53-55. PubMed ID: 28297060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular access outcomes and medication use: a USRDS study.
    Yevzlin AS; Conley EL; Sanchez RJ; Young HN; Becker BN
    Semin Dial; 2006; 19(6):535-9. PubMed ID: 17150056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dialysis arteriovenous access monitoring and surveillance according to the 2017 Spanish Guidelines.
    Roca-Tey R; Ibeas J; Moreno T; Gruss E; Merino JL; Vallespín J; Hernán D; Arribas P;
    J Vasc Access; 2018 Sep; 19(5):422-429. PubMed ID: 29544403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet therapy after endovascular intervention: does combination therapy really work and what is the optimum duration of therapy?
    Milani RV
    Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S7-S11. PubMed ID: 19213064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting hemodialysis access failure with the measurement of dialysis access recirculation.
    Hamidian Jahromi A; Morsy M; Chemla E
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):486-7; author reply 487. PubMed ID: 19414961
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiplatelet agents for the prevention of arteriovenous fistula and graft thrombosis: a meta analysis.
    Coleman CI; Tuttle LA; Teevan C; Baker WL; White CM; Reinhart KM
    Int J Clin Pract; 2010 Aug; 64(9):1239-44. PubMed ID: 20455955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late stent thrombosis: problem or not?
    Somberg J; Weinberger J
    Am J Cardiol; 2007 Apr; 99(7):1020-3. PubMed ID: 17398205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.